Comparative evaluation of efficacy of biodentine, mineral trioxide aggregate, calcium hydroxide and glass ionomer cement as pulp capping agent in deep carious lesions - Trial PACTR202310667867616
Access comprehensive clinical trial information for PACTR202310667867616 through Pure Global AI's free database. This Not Applicable trial is sponsored by Adamu Abdullahi Biu and is currently Recruiting. The study focuses on Oral Health.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
other
Sponsor & Location
Adamu Abdullahi Biu
self
Timeline & Enrollment
Not Applicable
Jul 10, 2023
Jan 01, 1900
Summary
The treatment of deep carious lesions (DCLs) aims mainly to maintain the affected dentin on the pulpal floor, and promote formation of new dentine, thus preserving the pulp vitality. Several pulp capping agents have been used with controversial outcomes, leaving clinicians to determine the most satisfactory agent in their practice. The purpose of this study was to clinically and radiographically compare and evaluate four types of indirect pulp capping (IPC) agents used in management of DCLs.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR202310667867616
Non-Device Trial